Metastatic Colorectal Cancer Trends and Forecast
The future of the global metastatic colorectal cancer market looks promising with opportunities in the hospital, cancer center, and ambulatory surgical center markets. The global metastatic colorectal cancer market is expected to grow with a CAGR of 4.3% from 2024 to 2030. The major drivers for this market are growing incidence of metastatic colorectal cancer globally, rising advancements in cancer research, and introduction of targeted therapies such as monoclonal antibodies.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Metastatic Colorectal Cancer by Segment
The study includes a forecast for the global metastatic colorectal cancer by treatment, drug class, end use, and region.
Metastatic Colorectal Cancer Market by Treatment [Shipment Analysis by Value from 2018 to 2030]:
• Chemotherapy
• Targeted Therapies
• Immunotherapies
• Monotherapy & Combination Therapy
• Others
Metastatic Colorectal Cancer Market by Drug Class [Shipment Analysis by Value from 2018 to 2030]:
• Anti-EGFR Inhibitors
• Anti-VEGF Therapies
• Anti-HER2 Therapies
• Immune Checkpoint Inhibitors
• Others
Metastatic Colorectal Cancer Market by End Use [Shipment Analysis by Value from 2018 to 2030]:
• Hospitals
• Cancer Centers
• Ambulatory Surgical Centers
• Others
Metastatic Colorectal Cancer Market by Region [Shipment Analysis by Value from 2018 to 2030]:
• North America
• Europe
• Asia Pacific
• The Rest of the World
List of Metastatic Colorectal Cancer Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies metastatic colorectal cancer companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the metastatic colorectal cancer companies profiled in this report include-
• Amgen
• EMD Serono
• Eli Lilly
• Genentech
• Novartis
• Pfizer
• F. Hoffmann-La Roche
• Sanofi
• Suzhou Zelgen Biopharmaceuticals
• Taiho Oncology
Metastatic Colorectal Cancer Market Insights
Lucintel forecasts that chemotherapy is expected to witness the highest growth over the forecast period.
Within this market, hospital is expected to witness the highest growth over the forecast period.
North America is expected to witness highest growth over the forecast period.
Features of the Global Metastatic Colorectal Cancer Market
Market Size Estimates: Metastatic colorectal cancer market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Metastatic colorectal cancer market size by treatment, drug class, end use, and region in terms of value ($B).
Regional Analysis: Metastatic colorectal cancer market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different treatments, drug classes, end uses, and regions for the metastatic colorectal cancer market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the metastatic colorectal cancer market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q1. What is the growth forecast for metastatic colorectal cancer market?
Answer: The global metastatic colorectal cancer market is expected to grow with a CAGR of 4.3% from 2024 to 2030.
Q2. What are the major drivers influencing the growth of the metastatic colorectal cancer market?
Answer: The major drivers for this market are growing incidence of metastatic colorectal cancer globally, rising advancements in cancer research, and introduction of targeted therapies such as monoclonal antibodies.
Q3. What are the major segments for metastatic colorectal cancer market?
Answer: The future of the metastatic colorectal cancer market looks promising with opportunities in the hospital, cancer center, and ambulatory surgical center markets.
Q4. Who are the key metastatic colorectal cancer market companies?
Answer: Some of the key metastatic colorectal cancer companies are as follows:
• Amgen
• EMD Serono
• Eli Lilly
• Genentech
• Novartis
• Pfizer
• F. Hoffmann-La Roche
• Sanofi
• Suzhou Zelgen Biopharmaceuticals
• Taiho Oncology
Q5. Which metastatic colorectal cancer market segment will be the largest in future?
Answer: Lucintel forecasts that chemotherapy is expected to witness the highest growth over the forecast period.
Q6. In metastatic colorectal cancer market, which region is expected to be the largest in next 5 years?
Answer: North America is expected to witness highest growth over the forecast period.
Q7. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the metastatic colorectal cancer market by treatment (chemotherapy, targeted therapies, immunotherapies, monotherapy & combination therapy, and others), drug class (anti-EGFR inhibitors, anti-VEGF therapies, anti-HER2 therapies, immune checkpoint inhibitors, and others), end use (hospitals, cancer centers, ambulatory surgical centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Metastatic Colorectal Cancer Market, Metastatic Colorectal Cancer Market Size, Metastatic Colorectal Cancer Market Growth, Metastatic Colorectal Cancer Market Analysis, Metastatic Colorectal Cancer Market Report, Metastatic Colorectal Cancer Market Share, Metastatic Colorectal Cancer Market Trends, Metastatic Colorectal Cancer Market Forecast, Metastatic Colorectal Cancer Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.